AN2 Therapeutics, Inc.（ANTX）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 AN2 Therapeutics, Inc.（ANTX）报告了 52 笔 Form 4 交易（最近一笔 2026-09-16）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-16 | Trenor Cameron C. III | Chief Medical Officer | 买入 | 116,667 | $0 |
| 2026-09-11 | Readnour Robin Shane | 董事 | 卖出 | 523 | $3,151 |
| 2026-09-11 | Readnour Robin Shane | 董事 | 卖出 | 585 | $3,524 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 2,877 | $17,463 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 3,223 | $19,563 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 4,725 | $28,436 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 5,294 | $31,861 |
| 2026-09-04 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 272 | $1,504 |
| 2026-09-02 | FitzPatrick Margaret M | 董事 | 买入 | 2,098 | $11,602 |
| 2026-08-19 | Readnour Robin Shane | 董事 | 卖出 | 16,696 | $100,313 |
| 2026-08-19 | Readnour Robin Shane | 董事 | 卖出 | 18,706 | $112,389 |
| 2026-08-14 | Zakrzewski Joseph S | 董事 | 卖出 | 405,880 | $0 |
| 2026-07-10 | Martin Patricia A. | 董事 | 买入 | 766 | $0 |
| 2026-07-10 | Aziz Kabeer | 董事 | 买入 | 2,852 | $0 |
| 2026-07-10 | Marks Gilbert Lynn | 董事 | 买入 | 2,789 | $0 |
| 2026-07-10 | Eizen Joshua M | See Remarks | 卖出 | 5,945 | $24,803 |
| 2026-06-02 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 265 | $1,174 |
| 2026-04-10 | Aziz Kabeer | 董事 | 买入 | 3,775 | $0 |
| 2026-04-10 | Martin Patricia A. | 董事 | 买入 | 1,192 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | 董事 | 买入 | 3,775 | $0 |
| 2026-03-05 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 327 | $347 |
| 2026-02-23 | Chanda Sanjay | Chief Development Officer | 买入 | 38,000 | $0 |
| 2026-02-23 | Day Lucy | Chief Financial Officer | 买入 | 38,000 | $0 |
| 2026-02-23 | Williams Sarah Joanne | Principal Accounting Officer | 买入 | 48,375 | $0 |
| 2026-02-23 | Easom Eric | Chief Executive Officer | 买入 | 112,250 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16